{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:30:45Z","timestamp":1760956245308,"version":"3.41.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011731","name":"Action for A-T","doi-asserted-by":"publisher","award":["20NOT05 David Peake Fund"],"award-info":[{"award-number":["20NOT05 David Peake Fund"]}],"id":[{"id":"10.13039\/100011731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Ataxia\u2013telangiectasia (A\u2013T) is an inherited multiorgan disorder with onset in childhood. Liver involvement, with steatosis and subsequent fibrosis, is increasingly recognized in children and young people with A\u2013T.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To evaluate feasibility of T1-weighted two-point mDixon MRI for identification of liver steatosis in children with A\u2013T and conduct exploratory analysis of relationships between MRI-quantified liver fat fraction and clinical and laboratory measures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Study type<\/jats:title>\n            <jats:p>Post hoc analysis of prospectively collected research data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Population<\/jats:title>\n            <jats:p>16 participants (8 female) with A\u2013T aged 4.8\u201316.6\u00a0years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Field strength\/sequence<\/jats:title>\n            <jats:p>3.0-T, two-point T1-weighted mDixon.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Assessment<\/jats:title>\n            <jats:p>Participants underwent whole-body MRI including T1-weighted mDixon. Water\/fat signal percentage images were generated. Hepatic T1 fat fraction (T1-FF) was calculated from regions-of-interest placed in the right anterior, right posterior and left hepatic lobes. T1-FF\u2009&gt;\u20095.56% was used as the diagnostic criterion for hepatic steatosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Statistical tests<\/jats:title>\n            <jats:p>Group comparisons of variables between participants with and without previous diagnosis of liver steatosis were made using independent sample Mann\u2013Whitney U. Associations between T1-FF and age, neurological severity and of liver function tests were tested with Spearman correlation. Statistical significance was pre-specified as p\u2009&lt;\u20090.05.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Analyzable T1-weighted mDixon data was available for 11 participants. Five MRI datasets were discarded due to motion artefact (n\u2009=\u20093) or incorrect archiving of the original water image (n\u2009=\u20092). Median liver T1-FF was 11.3% (4.7\u201349.7%), and 10\/11 (91%) of participants had evidence of steatosis. Participants with previous diagnosis of steatosis had higher T1-FF than those without (median 32.7% [9.7\u201349.7%], versus 10.3% [4.7\u201311.3%], <jats:italic>p<\/jats:italic>\u2009=\u20090.030). T1-FF correlated most strongly with alanine transaminase (r\u2009=\u20090.76, <jats:italic>p<\/jats:italic>\u2009=\u20090.007) and \u03b3-glutamyltransferase (r\u2009=\u20090.76, <jats:italic>p<\/jats:italic>\u2009=\u20090.006).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>T1-weighted mDixon MRI is feasible for detecting steatosis in children with A\u2013T, although motion artefacts reduced data completeness. MRI-quantified liver T1-FF correlates with markers of liver health. We found higher prevalence of liver steatosis using T1-weighted mDIXON than previously reported in pediatric A\u2013T cohorts.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03786-1","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T23:59:08Z","timestamp":1750463948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quantification of liver fat fraction using T1-weighted mDixon MRI in young patients with ataxia telangiectasia undergoing whole-body MRI: an exploratory study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5541-3847","authenticated-orcid":false,"given":"Soma","family":"Kumasaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafal","family":"Panek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohnish","family":"Suri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Jagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Kumasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Dineen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"3786_CR1","unstructured":"Dineen RA WW: Ataxia telangiectasia. In: Groul DL, Koibuchi N, Manto M, Molinari M, Schmahmann JD, Shen Y (editors). Essentials of cerebellum and cerebellar disorders. https:\/\/www.academia.edu\/43774280\/Essentials_of_Cerebellum_and_Cereb. 43774280."},{"key":"3786_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-016-0543-7","volume":"11","author":"C Rothblum-Oviatt","year":"2016","unstructured":"Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016;11:1\u201321.","journal-title":"Orphanet J Rare Dis"},{"key":"3786_CR3","doi-asserted-by":"crossref","unstructured":"Petley E, Yule A, Alexander S, Ojha S, Whitehouse WP. The natural history of ataxia\u2013telangiectasia (A\u2013T): a systematic review, vol 17; 2022.","DOI":"10.1371\/journal.pone.0264177"},{"key":"3786_CR4","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/bjc.2011.266","volume":"105","author":"A Reiman","year":"2011","unstructured":"Reiman A, Srinivasan V, Barone G, et al. Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours. Br J Cancer. 2011;105:586\u201391.","journal-title":"Br J Cancer"},{"key":"3786_CR5","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.4161\/cc.9.24.14323","volume":"9","author":"Z Guo","year":"2010","unstructured":"Guo Z, Deshpande R, Paull TT. ATM activation in the presence of oxidative stress. Cell Cycle. 2010;9:4805\u201311.","journal-title":"Cell Cycle"},{"key":"3786_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1568-7864(01)00007-6","volume":"1","author":"A Barzilai","year":"2002","unstructured":"Barzilai A, Rotman G, Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair. 2002;1:3\u201325.","journal-title":"DNA Repair"},{"key":"3786_CR7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/MPG.0000000000001036","volume":"62","author":"B Weiss","year":"2016","unstructured":"Weiss B, Krauthammer A, Soudack M, et al. Liver disease in pediatric patients with ataxia telangiectasia: a novel report. J Pediatr Gastroenterol Nutr. 2016;62:550\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3786_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2019.00458","volume":"7","author":"H Donath","year":"2019","unstructured":"Donath H, Woelke S, Theis M, et al. Progressive liver disease in patients with ataxia telangiectasia. Front Pediatr. 2019;7:1\u20138.","journal-title":"Front Pediatr"},{"key":"3786_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/761250","volume":"2014","author":"T Caballero","year":"2014","unstructured":"Caballero T, Caba-Molina M, Salmer\u00f3n J, G\u00f3mez-Morales M. Nonalcoholic steatohepatitis in a patient with ataxia\u2013telangiectasia. Case Rep Hepatol. 2014;2014:1\u20135.","journal-title":"Case Rep Hepatol"},{"key":"3786_CR10","first-page":"539","volume":"15","author":"D Joy","year":"2003","unstructured":"Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: Is biopsy necessary? Eur J Gastroenterol Hepatol. 2003;15:539\u201343.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3786_CR11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/SLA.0b013e3181bcd6dd","volume":"250","author":"AM El-Badry","year":"2009","unstructured":"El-Badry AM, Breitenstein S, Jochum W, et al. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg. 2009;250:691\u20136.","journal-title":"Ann Surg"},{"key":"3786_CR12","first-page":"66","volume":"6","author":"H Donath","year":"2023","unstructured":"Donath H, W\u00f6lke S, Knop V, et al. Liver assessment in patients with ataxia\u2013telangiectasia: transient elastography detects early stages of steatosis and fibrosis. Can J Gastroenterol Hepatol. 2023;6:66.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"3786_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-023-02720-7","volume":"18","author":"TLN Barreto","year":"2023","unstructured":"Barreto TLN, de Carvalho Filho RJ, Shigueoka DC, et al. Hepatic fibrosis: a manifestation of the liver disease evolution in patients with ataxia\u2013telangiectasia. Orphanet J Rare Dis. 2023;18:1\u201311.","journal-title":"Orphanet J Rare Dis"},{"key":"3786_CR14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/hepr.13179","volume":"48","author":"N Tamaki","year":"2018","unstructured":"Tamaki N, Koizumi Y, Hirooka M, et al. Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method. Hepatol Res. 2018;48:821\u20138.","journal-title":"Hepatol Res"},{"key":"3786_CR15","first-page":"665","volume":"1","author":"H Yin","year":"2024","unstructured":"Yin H, Fan Y, Yu J, et al. Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease. Insights Imaging. 2024;1:665.","journal-title":"Insights Imaging"},{"key":"3786_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/jmri.24568","volume":"40","author":"H Eggers","year":"2014","unstructured":"Eggers H, B\u00f6rnert P. Chemical shift encoding-based water-fat separation methods. J Magn Reson Imaging. 2014;40:251\u201368.","journal-title":"J Magn Reson Imaging"},{"key":"3786_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/diagnostics12020514","volume":"12","author":"V Brancato","year":"2022","unstructured":"Brancato V, Della Pepa G, Bozzetto L, et al. Evaluation of a whole-liver dixon-based MRI approach for quantification of liver fat in patients with type 2 diabetes treated with two isocaloric different diets. Diagnostics. 2022;12:66.","journal-title":"Diagnostics"},{"key":"3786_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70049","volume":"13","author":"R Neves","year":"2024","unstructured":"Neves R, Panek R, Clarkson K, et al. Feasibility of whole-body MRI for cancer screening in children and young people with ataxia telangiectasia: a mixed methods cross-sectional study. Cancer Med. 2024;13: e70049.","journal-title":"Cancer Med"},{"key":"3786_CR19","unstructured":"World Health Organization. BMI-for-age (5\u201319 years). https:\/\/www.who.int\/tools\/growth-reference-data-for-5to19-years\/indicators\/bmi-for-age."},{"key":"3786_CR20","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/dmcn.13052","volume":"58","author":"TJ Jackson","year":"2016","unstructured":"Jackson TJ, Chow G, Suri M, Byrd P, Taylor MR, Whitehouse WP. Longitudinal analysis of the neurological features of ataxia\u2013telangiectasia. Dev Med Child Neurol. 2016;58:690\u20137.","journal-title":"Dev Med Child Neurol"},{"key":"3786_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1259\/bjr.20170719","volume":"91","author":"HL McGlashan","year":"2018","unstructured":"McGlashan HL, Dineen RA, Szeszak S, et al. Evaluation of an internet-based animated preparatory video for children undergoing non-sedated MRI. Br J Radiol. 2018;91:66.","journal-title":"Br J Radiol"},{"key":"3786_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1177\/1367493518788476","volume":"23","author":"E Cavarocchi","year":"2019","unstructured":"Cavarocchi E, Pieroni I, Serio A, Velluto L, Guarnieri B, Sorbi S. Kitten scanner reduces the use of sedation in pediatric MRI. J Child Heal Care. 2019;23:256\u201365.","journal-title":"J Child Heal Care"},{"key":"3786_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2214\/AJR.14.12457","volume":"204","author":"MR Bashir","year":"2015","unstructured":"Bashir MR, Zhong X, Nickel MD, et al. Quantification of hepatic steatosis with a multistep adaptive fitting MRI approach: prospective validation against MR spectroscopy. Am J Roentgenol. 2015;204:297\u2013306.","journal-title":"Am J Roentgenol"},{"key":"3786_CR24","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3348\/kjr.2022.0334","volume":"23","author":"S Park","year":"2022","unstructured":"Park S, Kwon JH, Kim SY, et al. Cutoff values for diagnosing hepatic steatosis using contemporary MRI-proton density fat fraction measuring methods. Korean J Radiol. 2022;23:1260\u20138.","journal-title":"Korean J Radiol"},{"key":"3786_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/0100-3984.2023.0125","volume":"57","author":"A Gupta","year":"2024","unstructured":"Gupta A, Dixit R, Prakash A. Non-invasive hepatic fat quantification: Can multi-echo Dixon help? Radiol Bras. 2024;57:1\u20137.","journal-title":"Radiol Bras"},{"issue":"51\u20132","key":"3786_CR26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1152\/ajpendo.00064.2004","volume":"288","author":"LS Szczepaniak","year":"2005","unstructured":"Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288(51\u20132):462\u20138.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3786_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","volume":"54","author":"R Bender","year":"2001","unstructured":"Bender R, Lange S. Adjusting for multiple testing\u2014When and how? J Clin Epidemiol. 2001;54:343\u20139.","journal-title":"J Clin Epidemiol"},{"key":"3786_CR28","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S1474-4422(24)00220-5","volume":"23","author":"S Zielen","year":"2024","unstructured":"Zielen S, Crawford T, Benatti L, et al. Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. Lancet Neurol. 2024;23:871\u201382.","journal-title":"Lancet Neurol"},{"key":"3786_CR29","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41586-023-06277-0","volume":"619","author":"J Kim","year":"2023","unstructured":"Kim J, Woo S, de Gusmao CM, et al. A framework for individualized splice-switching oligonucleotide therapy. Nature. 2023;619:828\u201336.","journal-title":"Nature"},{"key":"3786_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/antiox11040653","volume":"11","author":"GN Subramanian","year":"2022","unstructured":"Subramanian GN, Yeo AJ, Gatei MH, Coman DJ, Lavin MF. Metabolic stress and mitochondrial dysfunction in ataxia-telangiectasia. Antioxidants. 2022;11:66.","journal-title":"Antioxidants"},{"key":"3786_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-017-0689-y","volume":"12","author":"TL Paulino","year":"2017","unstructured":"Paulino TL, Rafael MN, Hix S, et al. Is age a risk factor for liver disease and metabolic alterations in ataxia Telangiectasia patients? Orphanet J Rare Dis. 2017;12:1\u20137.","journal-title":"Orphanet J Rare Dis"},{"key":"3786_CR32","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1373\/clinchem.2006.081620","volume":"53","author":"L Kazemi-Shirazi","year":"2007","unstructured":"Kazemi-Shirazi L, Endler G, Winkler S, Schickbauer T, Wagner O, Marsik C. Gamma glutamyltransferase and long-term survival: Is it just the liver? Clin Chem. 2007;53:940\u20136.","journal-title":"Clin Chem"},{"key":"3786_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2008.10.052","volume":"136","author":"CE Ruhl","year":"2009","unstructured":"Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and \u03b3-glutamyltransferase and mortality in the united states population. Gastroenterology. 2009;136:477-485.e11.","journal-title":"Gastroenterology"},{"key":"3786_CR34","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1136\/bmj.38050.593634.63","volume":"328","author":"HC Kim","year":"2004","unstructured":"Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. Br Med J. 2004;328:983\u20136.","journal-title":"Br Med J"},{"issue":"July","key":"3786_CR35","first-page":"1","volume":"8","author":"H Donath","year":"2020","unstructured":"Donath H, Hess U, Kieslich M, et al. Diabetes in patients with ataxia telangiectasia: a National Cohort Study. Front Pediatr. 2020;8(July):1\u20138.","journal-title":"Front Pediatr"},{"key":"3786_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1056\/NEJM200102153440706","volume":"344","author":"AA Bravo","year":"2001","unstructured":"Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495\u2013500.","journal-title":"N Engl J Med"},{"issue":"September","key":"3786_CR37","first-page":"1","volume":"10","author":"K Jo\u0144czyk-Potoczna","year":"2022","unstructured":"Jo\u0144czyk-Potoczna K, Potoczny J, Szczawi\u0144ska-Pop\u0142onyk A. Imaging in children with ataxia\u2013telangiectasia\u2014the radiologist\u2019s approach. Front Pediatr. 2022;10(September):1\u201310.","journal-title":"Front Pediatr"},{"key":"3786_CR38","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jhep.2009.05.023","volume":"51","author":"NF Schwenzer","year":"2009","unstructured":"Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol. 2009;51:433\u201345.","journal-title":"J Hepatol"},{"key":"3786_CR39","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","volume":"123","author":"S Saadeh","year":"2002","unstructured":"Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745\u201350.","journal-title":"Gastroenterology"},{"key":"3786_CR40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00004424-200005000-00006","volume":"35","author":"M Graif","year":"2000","unstructured":"Graif M, Yanuka M, Baraz M, et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol. 2000;35:319\u201324.","journal-title":"Invest Radiol"},{"key":"3786_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/ueg2.12491","volume":"12","author":"J Li","year":"2024","unstructured":"Li J, Delamarre A, Wong VWS, de L\u00e9dinghen V. Diagnosis and assessment of disease severity in patients with nonalcoholic fatty liver disease. United Eur Gastroenterol J. 2024;12:219\u201325.","journal-title":"United Eur Gastroenterol J"},{"key":"3786_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1148\/radiol.10091790","volume":"256","author":"JR Van Werven","year":"2010","unstructured":"Van Werven JR, Marsman HA, Nederveen AJ, et al. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology. 2010;256:159\u201368.","journal-title":"Radiology"},{"key":"3786_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1148\/radiol.2511080666","volume":"251","author":"T Yokoo","year":"2009","unstructured":"Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology. 2009;251:67\u201376.","journal-title":"Radiology"},{"key":"3786_CR44","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.21037\/qims-20-989","volume":"11","author":"QH Zhang","year":"2021","unstructured":"Zhang QH, Zhao Y, Tian SF, et al. Hepatic fat quantification of magnetic resonance imaging whole-liver segmentation for assessing the severity of nonalcoholic fatty liver disease: comparison with a region of interest sampling method. Quant Imaging Med Surg. 2021;11:2933\u201342.","journal-title":"Quant Imaging Med Surg"},{"key":"3786_CR45","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/mrm.21301","volume":"58","author":"CY Liu","year":"2007","unstructured":"Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB. Fat quantification with IDEAL gradient echo imaging: correction of bias from T1 and noise. Magn Reson Med. 2007;58:354\u201364.","journal-title":"Magn Reson Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03786-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03786-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03786-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T01:01:11Z","timestamp":1750467671000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03786-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3786"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03786-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the UK Health Research Authority ref. 22\/YH\/0053 and was conducted in accordance with the ethical principles of the Declaration of Helsinki. Informed consent was obtained from the parent of participants aged under 16 years, or from the participant directly if aged 16\u201318 years.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}